Bliss GVS Pharma Bilan de santé
Santé financière contrôle des critères 6/6
Bliss GVS Pharma has a total shareholder equity of ₹10.5B and total debt of ₹832.9M, which brings its debt-to-equity ratio to 7.9%. Its total assets and total liabilities are ₹12.8B and ₹2.3B respectively. Bliss GVS Pharma's EBIT is ₹1.2B making its interest coverage ratio -36.2. It has cash and short-term investments of ₹2.2B.
Informations clés
7.9%
Ratio d'endettement
₹832.88m
Dette
| Ratio de couverture des intérêts | -36.2x |
| Argent liquide | ₹2.20b |
| Fonds propres | ₹10.48b |
| Total du passif | ₹2.34b |
| Total des actifs | ₹12.83b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Analyse de la situation financière
Passif à court terme: 506197's short term assets (₹8.5B) exceed its short term liabilities (₹1.9B).
Passif à long terme: 506197's short term assets (₹8.5B) exceed its long term liabilities (₹418.8M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 506197 has more cash than its total debt.
Réduire la dette: 506197's debt to equity ratio has reduced from 12.9% to 7.9% over the past 5 years.
Couverture de la dette: 506197's debt is well covered by operating cash flow (126.1%).
Couverture des intérêts: 506197 earns more interest than it pays, so coverage of interest payments is not a concern.